Access the latest press releases, media contacts, and press tools.
Discover how our people & technology are solving global issues, improving lives, and changing industries.
Voices is a network for GE’s US supporters interested in the company’s impact in their communities and in issues that impact the company.
Explore the latest stories, news, downloads, and press tools.
Get the latest GE stock data.
Tune in or catch up on GE’s latest investor events and reports.
Read the latest GE financial news releases and stories.
Explore GE’s recent and historic SEC filings.
Stay up to date with the latest resources for the planned spin-offs.
Access GE’s recent and historic Annual Reports and accompanying materials.
Read GE’s 2022 Proxy Statement, vote your shares and access the 2022 Annual Meeting.
Learn about governance at GE, including the latest Proxy Statement and information about the GE Board of Directors.
Access important shareholder information.
Get in touch and stay informed.
Learn how we’re delivering on our priorities.
Accomplished leaders building GE’s legacy.
Explore a timeline of GE technologies that have spurred transformation across the world.
At GE, we are committed to building a more diverse workforce and a more inclusive workplace.
Our energy expertise spans from renewable wind energy to emission-reducing natural gas, as well as physical and digital solutions to modernize the grid connecting it all.
A culture of integrity, compliance, safety, and respect for human rights, while reducing our environmental footprint.
Answers to popular and relevant inquiries.
Contact information for general inquiries and feedback.
We’re continuing to do all we can to support our customers and employees during this unprecedented time. We’re deeply proud of GE employees around the world rising to the challenge.
Our technology, global network, and exceptional team is fueled by a mission—building a world that works.
Find yourself a world changing job.
Learn more about our culture, businesses, and life at GE.
By embracing diverse teams and perspectives, we are better equipped to build a world that works.
At GE, we rise to the challenge of building a world that works. Explore a career with us.
Offering a suite of products to help unlock the full potential of additive manufacturing.
GE Aerospace is a world-leading provider of jet engines, components and systems for commercial and military aircraft with a global service network to support these offerings.
We connect capital to infrastructure and deliver innovative financial solutions that help make the world work better.
Transforming how industry solves its toughest challenges by bringing simplicity, speed and scale to digital transformation.
Creating the energy technologies of the future and improving the power networks that we depend on today.
Together with our customers, we’re proving that no one is ever limited to only affordable, reliable, or sustainable energy.
GE's innovation engine where ideas become reality to create a better world and deliver differentiated tech across the company's industrial portfolio.
Commercializing GE’s technology and IP to accelerate growth and achieve market differentiation.
GE's dedicated team, leading technology, and global reach and capabilities help the world work more efficiently, reliably, and safely.
A century ago, Sigmund Freud developed the radical idea that there is a lot more going on inside our heads that we know. Today, many doctors (and patients) still stick by his groundbreaking theory. But it comes with a problem. As neuroscientist Eric Kandel notes in his book The Age of Insight, “psychoanalysis suffered from a serious weakness: it was not empirical and was therefore not amenable to experimental testing.”
Until recently, much of modern medicine suffered from the same flaw. It was not until the early 1990s that “evidence-based medicine” took off. (See Google’s Ngram Viewer.) “Controlled clinical trials and formalized, evidence-based recommendations as to how medicine should be practiced is a fairly recent phenomenon,” says Deborah Kilpatrick, chief executive of the Silicon Valley startup Evidation Health.
Kilpatrick says that the same scientific rigor that the medical profession started applying to prescription drugs and devices now must expand to the booming digital realm including medical apps and remote monitoring devices. “We have a bias as a society that technology is good,” Kilpatrick says. “But it is imperative that we prove and validate it.”
Top image: Rat neurons captured by a digital microscope. Image credit: GE Healthcare Life Sciences
Evidation Health grew out of a 2014 meeting between Amir Dan Rubin, president and CEO of Stanford Health Care, and his GE counterpart Jeff Immelt. “They saw that there was a gap between new product claims and the evidence backing them up,” Kilpatrick says. “Proof of product value is actually much broader than just validating that something works. You need to demonstrate that the device can actually improve care in the real world and also be cost-efficient.”
That’s also the company’s business plan. Evidation Health will help digital health companies systematically test their products in real-world health systems, and measure their impact on cost and clinical outcomes.
Click here to download.
Evidation’s commercial progress has been accelerated by its relationships with GE Ventures, GE’s venture capital arm, and Stanford Health Care, an academic healthcare system with some 11,000 employees that operates a hospital, a trauma center, primary care centers and outpatient clinics throughout the Bay Area, as well as health plans. “Patients today face increasingly complex problems in managing their care,” says Amir Dan Rubin, president and CEO of Stanford Health Care. “At Stanford Health Care, we are committed to delivering integrated solutions to those complex problems, and those solutions will increasingly be advanced through digital health.“
Pravene Nath, Stanford Health Care’s chief information officer, says that the healthcare provider will be “much more than a sounding board” but a real-life test bed for digital devices. “It hasn’t been easy for companies both small and large to test the usefulness of their digital devices. Our goal is to solve that problem.”
The Journal of the American Medical Association recently cited a study that estimated the U.S. market for wearable monitoring devices alone will reach $50 billion by 2018. “The gap between recording information and changing behavior is substantial,” JAMA wrote, “and while these devices are increasing in popularity, little evidence suggests that they are bridging that gap.”
Kilpatrick says that in addition to startups, Evidation Health will work with established healthcare companies and health plans to develop and deploy digital health strategies. “Digital technologies are rapidly revolutionizing the entire healthcare ecosystem, allowing patients and physicians to interact anytime anywhere,” Kilpatrick says. “None of these things are a problem. Rather, they present us with an incredible opportunity to improve patient care in altogether new ways.”
For more reading go to Kilpatrick’s op-ed piece on Ideas Lab.